Fujita J, Yamagishi Y, Kubo A, Takigawa K, Yamaji Y, Takahara J
First Department of Internal Medicine, Kagawa Medical School, Japan.
Chest. 1993 Mar;103(3):967-8. doi: 10.1378/chest.103.3.967.
A man with primary lung cancer developed respiratory failure due to lymphangitis carcinomatosis that was diagnosed by transbronchial lung biopsy specimen. After combination chemotherapy with high-dose etoposide and cisplatin (CDDP), he was able to cease oxygen therapy and showed improvement of his lymphangitis carcinomatosis. He received a total dose of 13,400 mg/m2 of etoposide. This case suggested that respiratory failure due to lymphangitis carcinomatosis can be a treatable condition.
一名原发性肺癌患者因癌性淋巴管炎出现呼吸衰竭，经支气管肺活检标本确诊。在接受高剂量依托泊苷和顺铂（CDDP）联合化疗后，他能够停止吸氧治疗，且癌性淋巴管炎有所改善。他接受的依托泊苷总剂量为13400mg/m²。该病例表明，癌性淋巴管炎所致呼吸衰竭是一种可治疗的病症。
